PET-Driven Radiotherapy (RT) in Patients with Low Risk Diffuse Large B-Cell Lymphoma (DLBCL): 5-Year Results of the DLCL10 Multicenter Phase 2 Trial By Fondazione Italiana Linfomi (FIL)
Gespeichert in:
| Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.1765-1767 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1767 |
|---|---|
| container_issue | Supplement 1 |
| container_start_page | 1765 |
| container_title | Blood |
| container_volume | 140 |
| creator | Balzarotti, Monica Ricardi, Umberto Spina, Michele Evangelista, Andrea Tucci, Alessandra Cavallo, Federica Zanni, Manuela Arcari, Annalisa Zilioli, Vittorio Ruggero Sartori, Roberto Merli, Francesco Re, Francesca Vitolo, Umberto Deidda, Maria Assunta Melis, Luca Dessì, Daniela Rodari, Marcello Santoro, Armando Gaidano, Gianluca Ciccone, Giovannino Chauvie, Stephane Cabras, Maria Giuseppina |
| description | |
| doi_str_mv | 10.1182/blood-2022-159759 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_159759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122022789</els_id><sourcerecordid>S0006497122022789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1379-e90948086f9c21102ace545d0456338a3ce6b5d62adec93fa4fc110ca38773883</originalsourceid><addsrcrecordid>eNp9kE1vEzEQQC0EEqHwA7jNMTkYbO83nMimoZGMiKJw4LSaesfEsFlH9rZV-Gf8O9yGM6eRRvOeRo-xt1K8k7JW728H73uuhFJcFk1VNM_YTBaq5kIo8ZzNhBAlz5tKvmSvYvwphMwzVczYn-31nq-Cu6cRdtg7Px0o4OkM891-AW6ELU6OxinCg5sOoP0D7Fz8BStn7V0k0Bh-ECx5S8MA-nw8HfwRYb7Sy1YvPkDBvxMG2FG8G5LDW0h-WOlWSwFf0s6ZJKcA2wMmm4J9cDjA8gxrP_b42_mRYDPh4HBE0G60_uhgvt7oxWv2wuIQ6c2_ecW-ra_37Q3XXz9v2k-aG5lVDadGNHkt6tI2RkkpFBoq8qIXeVFmWY2ZofK26EuFPZkms5hbk84MZnVVZXWdXTF58ZrgYwxku1NwRwznTorusX331L57bN9d2ifm44Wh9Ni9o9BFkyoa6l0gM3W9d_-h_wLRK4pF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>PET-Driven Radiotherapy (RT) in Patients with Low Risk Diffuse Large B-Cell Lymphoma (DLBCL): 5-Year Results of the DLCL10 Multicenter Phase 2 Trial By Fondazione Italiana Linfomi (FIL)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Balzarotti, Monica ; Ricardi, Umberto ; Spina, Michele ; Evangelista, Andrea ; Tucci, Alessandra ; Cavallo, Federica ; Zanni, Manuela ; Arcari, Annalisa ; Zilioli, Vittorio Ruggero ; Sartori, Roberto ; Merli, Francesco ; Re, Francesca ; Vitolo, Umberto ; Deidda, Maria Assunta ; Melis, Luca ; Dessì, Daniela ; Rodari, Marcello ; Santoro, Armando ; Gaidano, Gianluca ; Ciccone, Giovannino ; Chauvie, Stephane ; Cabras, Maria Giuseppina</creator><creatorcontrib>Balzarotti, Monica ; Ricardi, Umberto ; Spina, Michele ; Evangelista, Andrea ; Tucci, Alessandra ; Cavallo, Federica ; Zanni, Manuela ; Arcari, Annalisa ; Zilioli, Vittorio Ruggero ; Sartori, Roberto ; Merli, Francesco ; Re, Francesca ; Vitolo, Umberto ; Deidda, Maria Assunta ; Melis, Luca ; Dessì, Daniela ; Rodari, Marcello ; Santoro, Armando ; Gaidano, Gianluca ; Ciccone, Giovannino ; Chauvie, Stephane ; Cabras, Maria Giuseppina</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-159759</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.1765-1767</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Balzarotti, Monica</creatorcontrib><creatorcontrib>Ricardi, Umberto</creatorcontrib><creatorcontrib>Spina, Michele</creatorcontrib><creatorcontrib>Evangelista, Andrea</creatorcontrib><creatorcontrib>Tucci, Alessandra</creatorcontrib><creatorcontrib>Cavallo, Federica</creatorcontrib><creatorcontrib>Zanni, Manuela</creatorcontrib><creatorcontrib>Arcari, Annalisa</creatorcontrib><creatorcontrib>Zilioli, Vittorio Ruggero</creatorcontrib><creatorcontrib>Sartori, Roberto</creatorcontrib><creatorcontrib>Merli, Francesco</creatorcontrib><creatorcontrib>Re, Francesca</creatorcontrib><creatorcontrib>Vitolo, Umberto</creatorcontrib><creatorcontrib>Deidda, Maria Assunta</creatorcontrib><creatorcontrib>Melis, Luca</creatorcontrib><creatorcontrib>Dessì, Daniela</creatorcontrib><creatorcontrib>Rodari, Marcello</creatorcontrib><creatorcontrib>Santoro, Armando</creatorcontrib><creatorcontrib>Gaidano, Gianluca</creatorcontrib><creatorcontrib>Ciccone, Giovannino</creatorcontrib><creatorcontrib>Chauvie, Stephane</creatorcontrib><creatorcontrib>Cabras, Maria Giuseppina</creatorcontrib><title>PET-Driven Radiotherapy (RT) in Patients with Low Risk Diffuse Large B-Cell Lymphoma (DLBCL): 5-Year Results of the DLCL10 Multicenter Phase 2 Trial By Fondazione Italiana Linfomi (FIL)</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1vEzEQQC0EEqHwA7jNMTkYbO83nMimoZGMiKJw4LSaesfEsFlH9rZV-Gf8O9yGM6eRRvOeRo-xt1K8k7JW728H73uuhFJcFk1VNM_YTBaq5kIo8ZzNhBAlz5tKvmSvYvwphMwzVczYn-31nq-Cu6cRdtg7Px0o4OkM891-AW6ELU6OxinCg5sOoP0D7Fz8BStn7V0k0Bh-ECx5S8MA-nw8HfwRYb7Sy1YvPkDBvxMG2FG8G5LDW0h-WOlWSwFf0s6ZJKcA2wMmm4J9cDjA8gxrP_b42_mRYDPh4HBE0G60_uhgvt7oxWv2wuIQ6c2_ecW-ra_37Q3XXz9v2k-aG5lVDadGNHkt6tI2RkkpFBoq8qIXeVFmWY2ZofK26EuFPZkms5hbk84MZnVVZXWdXTF58ZrgYwxku1NwRwznTorusX331L57bN9d2ifm44Wh9Ni9o9BFkyoa6l0gM3W9d_-h_wLRK4pF</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Balzarotti, Monica</creator><creator>Ricardi, Umberto</creator><creator>Spina, Michele</creator><creator>Evangelista, Andrea</creator><creator>Tucci, Alessandra</creator><creator>Cavallo, Federica</creator><creator>Zanni, Manuela</creator><creator>Arcari, Annalisa</creator><creator>Zilioli, Vittorio Ruggero</creator><creator>Sartori, Roberto</creator><creator>Merli, Francesco</creator><creator>Re, Francesca</creator><creator>Vitolo, Umberto</creator><creator>Deidda, Maria Assunta</creator><creator>Melis, Luca</creator><creator>Dessì, Daniela</creator><creator>Rodari, Marcello</creator><creator>Santoro, Armando</creator><creator>Gaidano, Gianluca</creator><creator>Ciccone, Giovannino</creator><creator>Chauvie, Stephane</creator><creator>Cabras, Maria Giuseppina</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>PET-Driven Radiotherapy (RT) in Patients with Low Risk Diffuse Large B-Cell Lymphoma (DLBCL): 5-Year Results of the DLCL10 Multicenter Phase 2 Trial By Fondazione Italiana Linfomi (FIL)</title><author>Balzarotti, Monica ; Ricardi, Umberto ; Spina, Michele ; Evangelista, Andrea ; Tucci, Alessandra ; Cavallo, Federica ; Zanni, Manuela ; Arcari, Annalisa ; Zilioli, Vittorio Ruggero ; Sartori, Roberto ; Merli, Francesco ; Re, Francesca ; Vitolo, Umberto ; Deidda, Maria Assunta ; Melis, Luca ; Dessì, Daniela ; Rodari, Marcello ; Santoro, Armando ; Gaidano, Gianluca ; Ciccone, Giovannino ; Chauvie, Stephane ; Cabras, Maria Giuseppina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1379-e90948086f9c21102ace545d0456338a3ce6b5d62adec93fa4fc110ca38773883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balzarotti, Monica</creatorcontrib><creatorcontrib>Ricardi, Umberto</creatorcontrib><creatorcontrib>Spina, Michele</creatorcontrib><creatorcontrib>Evangelista, Andrea</creatorcontrib><creatorcontrib>Tucci, Alessandra</creatorcontrib><creatorcontrib>Cavallo, Federica</creatorcontrib><creatorcontrib>Zanni, Manuela</creatorcontrib><creatorcontrib>Arcari, Annalisa</creatorcontrib><creatorcontrib>Zilioli, Vittorio Ruggero</creatorcontrib><creatorcontrib>Sartori, Roberto</creatorcontrib><creatorcontrib>Merli, Francesco</creatorcontrib><creatorcontrib>Re, Francesca</creatorcontrib><creatorcontrib>Vitolo, Umberto</creatorcontrib><creatorcontrib>Deidda, Maria Assunta</creatorcontrib><creatorcontrib>Melis, Luca</creatorcontrib><creatorcontrib>Dessì, Daniela</creatorcontrib><creatorcontrib>Rodari, Marcello</creatorcontrib><creatorcontrib>Santoro, Armando</creatorcontrib><creatorcontrib>Gaidano, Gianluca</creatorcontrib><creatorcontrib>Ciccone, Giovannino</creatorcontrib><creatorcontrib>Chauvie, Stephane</creatorcontrib><creatorcontrib>Cabras, Maria Giuseppina</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balzarotti, Monica</au><au>Ricardi, Umberto</au><au>Spina, Michele</au><au>Evangelista, Andrea</au><au>Tucci, Alessandra</au><au>Cavallo, Federica</au><au>Zanni, Manuela</au><au>Arcari, Annalisa</au><au>Zilioli, Vittorio Ruggero</au><au>Sartori, Roberto</au><au>Merli, Francesco</au><au>Re, Francesca</au><au>Vitolo, Umberto</au><au>Deidda, Maria Assunta</au><au>Melis, Luca</au><au>Dessì, Daniela</au><au>Rodari, Marcello</au><au>Santoro, Armando</au><au>Gaidano, Gianluca</au><au>Ciccone, Giovannino</au><au>Chauvie, Stephane</au><au>Cabras, Maria Giuseppina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PET-Driven Radiotherapy (RT) in Patients with Low Risk Diffuse Large B-Cell Lymphoma (DLBCL): 5-Year Results of the DLCL10 Multicenter Phase 2 Trial By Fondazione Italiana Linfomi (FIL)</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>1765</spage><epage>1767</epage><pages>1765-1767</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-159759</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.1765-1767 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_crossref_primary_10_1182_blood_2022_159759 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | PET-Driven Radiotherapy (RT) in Patients with Low Risk Diffuse Large B-Cell Lymphoma (DLBCL): 5-Year Results of the DLCL10 Multicenter Phase 2 Trial By Fondazione Italiana Linfomi (FIL) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A48%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PET-Driven%20Radiotherapy%20(RT)%20in%20Patients%20with%20Low%20Risk%20Diffuse%20Large%20B-Cell%20Lymphoma%20(DLBCL):%205-Year%20Results%20of%20the%20DLCL10%20Multicenter%20Phase%202%20Trial%20By%20Fondazione%20Italiana%20Linfomi%20(FIL)&rft.jtitle=Blood&rft.au=Balzarotti,%20Monica&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=1765&rft.epage=1767&rft.pages=1765-1767&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-159759&rft_dat=%3Celsevier_cross%3ES0006497122022789%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122022789&rfr_iscdi=true |